Nutriband Inc. (NTRB)
NASDAQ: NTRB · IEX Real-Time Price · USD
4.860
-0.230 (-4.52%)
At close: May 16, 2024, 3:31 PM
4.740
-0.120 (-2.47%)
After-hours: May 16, 2024, 4:04 PM EDT
Nutriband Revenue
In the fiscal year ending January 31, 2024, Nutriband had annual revenue of $2.09M with 0.27% growth. Revenue in the quarter ending January 31, 2024 was $524.61K, a -0.55% decrease year-over-year.
Revenue (ttm)
$2.09M
Revenue Growth
+0.27%
P/S Ratio
26.79
Revenue / Employee
$160,409
Employees
13
Market Cap
53.09M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jan 31, 2024 | 2.09M | 5.71K | 0.27% |
Jan 31, 2023 | 2.08M | 657.46K | 46.23% |
Jan 31, 2022 | 1.42M | 478.45K | 50.70% |
Jan 31, 2021 | 943.70K | 573.06K | 154.61% |
Jan 31, 2020 | 370.65K | 125.36K | 51.11% |
Jan 31, 2019 | 245.29K | - | - |
Jan 31, 2018 | 0 | - | - |
Jan 31, 2017 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Cidara Therapeutics | 46.38M |
Carisma Therapeutics | 15.07M |
Enzo Biochem | 12.81M |
EUDA Health Holdings | 3.71M |
Envoy Medical | 297.00K |
Checkpoint Therapeutics | 68.00K |
NTRB News
- 10 hours ago - Nutriband Appoints Accomplished Business Leader Sergei Glinka to its Board of Directors - Accesswire
- 6 days ago - Can-Fite BioPharma and Nutriband Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Accesswire
- 23 days ago - Nutriband Inc. Signs Exclusive Supplier Agreement with Major Sports Brand Licensee Fit for Life Group - Accesswire
- 27 days ago - Nutriband Inc. Announces $8.4M Private Placement - Accesswire
- 7 weeks ago - Nutriband Announces Data Supporting Need for Safer Abuse-Deterrent Transdermal Patches Presented at 2024 American Academy of Pain Medicine Annual Meeting - Accesswire
- 2 months ago - Prescription Transdermal Patch Abuse and Accidental Pediatric Exposure Remains a Serious Problem in the United States - Surveillance Data to Be Presented at 2024 American Academy of Pain Medicine Annual Meeting - Accesswire
- 3 months ago - Nutriband Inc. to Present at The Microcap Conference Atlantic City January 30th through February 1st - Accesswire
- 3 months ago - Nutriband CEO Publishes Letter to Shareholders - Accesswire